This clinical trial report provides an overview of the Coronavirus Disease 2019 (COVID-19) Clinical trials scenario.
The report provides top line data relating to the clinical trials on Coronavirus Disease 2019 (COVID-19). The report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. The report also provides prominent drugs for in-progress trials (based on number of ongoing trials).
Report Scope
The report provides a snapshot of the global clinical trials landscape
The report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
The report provides enrollment trends for the past five years
The report provides latest news for the past three months
Reasons to Buy
Assists in formulating key business strategies with regards to investment
Helps in identifying prominent locations for conducting clinical trials which saves time and cost
Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
Supports understanding of trials count and enrollment trends by country in global therapeutics market
Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
Facilitates clinical trial assessment of the indication on a global, regional and country level
Key Topics Covered
1. Report Guidance
2. Clinical Trials Report Coverage
Clinical Trials by Region
Clinical Trials and Average Enrollment by Country
Top Five Countries Contributing to Clinical Trials in Asia-Pacific
Top Five Countries Contributing to Clinical Trials in Europe
Top Countries Contributing to Clinical Trials in North America
Top Five Countries Contributing to Clinical Trials in Middle East and Africa
Top Five Countries Contributing to Clinical Trials in Central and South America
Clinical Trials by G7 Countries: Proportion of Coronavirus Disease 2019 (COVID-19) to Infectious Disease Clinical Trials
Clinical Trials by Phase in G7 Countries
Clinical Trials in G7 Countries by Trial Status
Clinical Trials by E7 Countries: Proportion of Coronavirus Disease 2019 (COVID-19) to Infectious Disease Clinical Trials
Clinical Trials by Phase in E7 Countries
Clinical Trials in E7 Countries by Trial Status
3. Clinical Trials by Phase
In Progress Trials by Phase
Clinical Trials by Trial Status
Clinical Trials by End Point Status
4. Clinical Trials by Sponsor Type
Prominent Sponsors
Top Companies Participating in Coronavirus Disease 2019 (COVID-19) Therapeutics Clinical Trials
Prominent Drugs
Clinical Trial Profile Snapshots
Companies Mentioned
Sanofi
Novartis AG
F. Hoffmann-La Roche Ltd.
AstraZeneca PLC
Guangzhou Reborn Health Management Consultation Co. Ltd.
Ventilation and arena upgrades are now complete in four community buildings in the province after an investment of $3,401,324 from the federal government.
Announced by Minister Sean Fraser, these projects are located in St. Albert, Tsuut'ina Nation,...
According to Arizton's latest research report, the global pressure washer market is growing at a CAGR of 4.32% during the forecast period.
To Know More, Click: https://www.arizton.com/market-reports/global-pressure-washer-market-size-analysis...
The "Global Immunoprecipitation Testing - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029" report has been added to ResearchAndMarkets.com's offering.
The Global Immunoprecipitation Testing Market size is estimated...
The "Global Sports Optics Market: Analysis By Type, By Region Size and Trends with Impact of COVID-19 and Forecast up to 2029" report has been added to ResearchAndMarkets.com's offering.
The global sports optics market value stood at US$2.17 in...
Glancy Prongay & Murray LLP ("GPM") announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Nextdoor Holdings, Inc. f/k/a Khosla Ventures Acquisition Co. II ("Nextdoor" or the...
This year marks the 14th anniversary of the enactment of the Affordable Care Act (ACA). Its passage was the most significant advancement of health policy since the establishment of Medicare and Medicaid in the 1960s and made healthcare accessible and...